Evotec AG 01.12.2014 15:57 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On November 28, 2014, Biotechnology Value Fund, L.P., Chicago, Illinois, United States has informed us according to Article 21, Section 1 of the WpHG that via shares its Voting Rights on Evotec AG, Hamburg, Germany, have exceeded the 3% threshold of the Voting Rights on November 28, 2014 and on that day amounted to 3.57% (this corresponds to 4706513 Voting Rights). 1.73% of Voting Rights (this corresponds to 2280324 Voting Rights) are attributed to the company in accordance with Article 22, Section 1, Sentence 1, No. 5 of the WpHG (German Securities Trading Act). Attributed Voting Rights are held by the following shareholders, whose share of the Voting Rights in Evotec AG amounts to 3 percent or more: TVM V Life Science Ventures GmbH & Co. KG. 01.12.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Evotec AG Manfred Eigen Campus / Essener Bogen 7 22419 Hamburg Germany Internet: www.evotec.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Evotec AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG